Patient-prosthetic aortic valve mismatch: Role of the echocardiographer

Echocardiography

Volumn 22, Issue 4, 2005, Pages 365-366

  Reagan, Brendan Wesley ^a   Kerut, Edmund Kenneth ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEART CLINIC OF LOUISIANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE PROSTHESIS; ARTICLE; BODY SURFACE; HEMODYNAMICS; MATHEMATICAL ANALYSIS; MEAN ARTERIAL PRESSURE; PATIENT PROSTHETIC AORTIC VALVE MISMATCH; PRESSURE GRADIENT; PRIORITY JOURNAL; PROSTHESIS FAILURE;

AORTIC VALVE STENOSIS; BIOPROSTHESIS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; PROSTHESIS FAILURE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 17644393156     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2005.40015.x     Document Type: Article

References (18)

1. Christakis GT, Buth KJ, Goldman BS, et al: Inaccurate and misleading valve sizing: A proposed standard for valve size nomenclature. Ann Thorac Surg 1998;66:1193-1203.
2. Rahimtoola SH: The problem of valve prosthesis-patient mismatch. Circulation 1978;58:20-24.
3. Dumesnil JG, Yoganathan AP: Valve prosthesis hemodynamics and the problem of high transprosthetic pressure gradients. Eur J Cardiothorac Surg 1992;6:S34-S38.
4. Pibarot P, Honos GN, Durand LG, et al: The effect of patient-prosthesis mismatch on aortic bioprosthetic valve hemodynamic performance and patient clinical status. Can J Cardiol 1996;12:379-387.
5. Pibarot P, Dumesnil JG, Lemieux M, et al: Impact of prosthesis-patient mismatch on hemodynamic and symptomatic status, morbidity, and mortality after aortic valve replacement with a bioprosthetic heart valve. J Heart Valve Dis 1998;7:211-218.
6. Pibarot P, Dumesnil JG: Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 2000;36:1131-1141.
7. Wang Y, Moss J, Thisted R: Predictors of body surface area. J Clin Anesth 1992;4:4-10.
8. Pibarot P, Dumesnil JG: Patient-prosthesis mismatch and the predictive use of indexed effective orifice area: Is it relevant? Cardiac Surg Today 2003;1:43-51.
9. Rahimtoola S: Valve prosthesis-patient mismatch: An update. J Heart Valve Dis 1998;7:207-210.
10. Blais C, Dumesnil JG, Baillot R, et al: Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 2003;108:983-988.
11. Rao V, Jamieson WRE, Ivanov J, et al: Prosthesis-patient mismatch affects survival following aortic valve replacement. Circulation 2000;102:III-5-III-9.
12. Del Rizzo DF, Abdoh A, Cartier P, et al: Factors affecting left ventricular mass regression after aortic valve replacement with stentless valves. Semin Thorac Cardiovasc Surg 1999;11:114-120.
13. Khan S, Siegel R, De Robertis M, et al: Regression of hypertrophy after Carpentier-Edwards pericardial aortic valve replacement. Ann Thorac Surg 2000;69:531-535.
14. Thomson DJ, Jamieson WR, Dumesnil JG, et al: Medtronic mosaic porcine bioprosthesis satisfactory early clinical performance. Ann Thorac Surg 1998;66:S122-S125.
15. Dossche K, Vanermen H, Daenen W, et al: Hemodynamic performance of the PRIMA Edwards Stentless Aortic Xenograft: Early results of a multicenter clinical trial. Thorac Cardiovasc Surg 1996;44:11-14.
16. CarboMedics, Inc. Pre-Market Approval Application - Summary of Safety and Effectiveness. U.S. Food and Drug Administration, P900060, Washington D.C.
17. Plehn J, Arbuckle B, Southworth J, et al: A hemodynamic comparison of omniscience and medtronic hall aortic prostheses. J Heart Value Dis 1996;5:328-336.
18. St. Jude Medical, Inc. Pre-Market Approval Application - Summary of Safety and Effectiveness. U.S. Food and Drug Administration, P810002/S57, Washington, D.C.